Edwina Baskin-Bey

Fight Cancer Global, LLC provides a network platform aimed at solving the isolation problems faced by cancer patients. The private company is based in Houston, TX.

Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC.

Catalyst Clinical Research LLC engages in the provision of staffing resources to the biotechnology, pharmaceutical and medical device companies. It offers augmented contract staff, monitoring teams, CRO oversight and medical writing services. The company was founded by Betsy Brown and Jean Hendrickson n 2013 and is headquartered in Durham, NC.